By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Genmab A/S 

Toldbodgade 33

Copenhagen    K-1253  Denmark
Phone: 45-7020-2728 Fax: 45-7020-2729


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Genmab A/S
Employees:
Symbol: GEN.CO
 



Industry
Biotechnology


Collaborations

Bionomics Limited  Anti-angiogenesis therapeutic antibody development





Company News
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014 10:23:44 AM
Genmab A/S (GEN.CO) Announces New Phase 3 Study Of Daratumumab In Front Line Multiple Myeloma 8/11/2014 7:34:33 AM
Genmab A/S (GEN.CO), GlaxoSmithKline (GSK)'s Ofatumumab Meets Primary Endpoint In Late-Stage Study 8/1/2014 6:24:10 AM
Genmab A/S (GEN.CO) Announces Phase 3 Study Of Daratumumab In Front Line Multiple Myeloma 7/18/2014 7:43:42 AM
Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. (JNJ) 7/14/2014 9:04:36 AM
GlaxoSmithKline (GSK) And Genmab A/S (GEN.CO) Receive EU Authorization For Arzerra™ (Ofatumumab) As First-Line Treatment For Chronic Lymphocytic Leukemia (CLL) In Combination With Chlorambucil Or Bendamustine For Patients Ineligible For Fludarabine-Based Therapy 7/3/2014 8:59:10 AM
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Leukemia Drug Ofatumumab Fails To Meet Main Trial Goal 6/30/2014 5:51:07 AM
Genmab A/S (GEN.CO) Reaches USD 25 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 6/16/2014 11:55:35 AM
Articles Of Association For Genmab A/S (GEN.CO) 6/16/2014 7:33:56 AM
Grant Of Warrants To Genmab A/S (GEN.CO) Employees 6/13/2014 8:12:13 AM
12345678910...
//-->